Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. by Porpiglia, Francesco et al.
 
 
This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is posted here 
by agreement between Elsevier and the University of Turin. Changes resulting from the publishing 
process - such as editing, corrections, structural formatting, and other quality control mechanisms - 




Retrospective Evaluation of the Outcome of Open Versus 
Laparoscopic Adrenalectomy for Stage I and II 
Adrenocortical Cancer 
 
Volume: 57      
Issue: 5 
Pages: 873-878 





You may download, copy and otherwise use the AAM for non-commercial purposes provided that 
your license is limited by the following restrictions: 
 
(1) You may use this AAM for non-commercial purposes only under the terms of the CC-BY-NC-ND 
license.  
(2) The integrity of the work and identification of the author, copyright owner, and publisher must be 
preserved in any copy.  








Although there is consensus that laparoscopy is the standard of care for the resection of benign adrenal 
tumours, there is controversy regarding the role of laparoscopy for the resection of adrenocortical cancer 
(ACC). 
Objective 
The aim of the present study was to review the ACC database of the San Luigi Hospital to compare the 
oncologic effectiveness of open adrenalectomy (OA) versus laparoscopic adrenalectomy (LA) in the 
treatment of patients with stage I and II ACC. 
Design, setting, and participants 
We performed a retrospective analysis involving 43 patients with stage I and II ACC who had undergone 
radical surgery. 
Intervention 
The patients were stratified into two groups according to the surgical procedure. The “open group” 
consisted of patients treated with OA; the “lap group” consisted of patients treated with LA. 
Measurements 
Oncologic effectiveness of the procedures was tested comparing the recurrence-free survival of patients 
treated with OA versus LA. Secondary outcome measures were differences in terms of type of recurrence 
and overall survival. 
Results and limitations 
The open group consisted of 25 patients and the lap group of 18 patients. The two groups were 
comparable in terms of demographic data. The median follow-up was 38 mo in the open group and 30 mo 
in the lap group. Recurrence rate was 64% in the open group and 50% in the lap group. The median 
recurrence-free survival was 18 mo in the open group and 23 in the lap group (p = 0.8). No differences in 
terms of pattern of recurrences were recorded. During follow-up, 28% of the open group patients and 5% 
of the lap group patients died. No differences in terms of survival time were noted (p = 0.3). 
Conclusions 
The present findings provide interesting evidence that OA and LA may be comparable in terms of 
recurrence-free survival for patients with stage I and II ACC when the principles of surgical oncology are 
respected. 
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Adrenal tumours represent a wide spectrum of pathologies ranging from benign adenoma to adrenocortical 
carcinoma (ACC), and indications for adrenalectomy include hormone secretion and/or perceived risk of 
malignancy (ie, tumour size, radiographic features, local invasion, lymph node involvement, or distant 
metastases) [1], [2], [3], [4], [5] and [6]. 
When the adrenal tumour is small and shows a benign imaging phenotype, there is a general consensus 
on the type of surgical approach because laparoscopy has become the first option for this kind of lesion [7] 
and [8]. However, when a malignant tumour is suspected and surrounding tissues are involved, open 
adrenalectomy is clearly indicated [9] and [10]. But when the lesion is >4–6 cm and/or there are radiologic 
features that increase the risk of malignancy without a clear involvement of adjacent organs, the optimal 
surgical approach is still to be defined. 
In the case of ACC, which is a rare but extremely aggressive neoplasm, surgery is the only potentially 
curative treatment, so the choice of surgical strategy is crucial for the patient's outcome. Open surgery is 
usually considered the best surgical treatment, but some authors have published on the use of 
laparoscopy; nevertheless, only a few laparoscopic cases have been reported [11], [12], [13] and [14]. 
The aim of the present study was to review the ACC database of the San Luigi Hospital to compare the 
oncologic effectiveness of open versus laparoscopic adrenalectomy in the treatment of patients with ACC. 
2. Patients and methods 
2.1. Adrenocortical carcinoma database of the San Luigi Hospital 
The ACC database was established in 2001 with the development of a structured data form to collect 
comprehensive information on all patients with ACC who were referred to our Centre for Diagnosis and 
Treatment of Adrenal Diseases. All data were obtained by reviewing patients’ histories, discharge 
summaries, medical records, and source documents. Data were retrieved by trained medical personnel 
using specifically tailored data forms. For the purpose of this study, data of patients referred between 
January 2002 and June 2008 were considered. We included patients who underwent radical surgery either 
at our centre (operated by a single surgeon, FP) or at other institutions before referral to us. These 
institutions are secondary centres for adrenal diseases but usually refer patients with ACC to us for 
postoperative management and treatment. Follow-up for this study was closed in June 2009. The 
institutional ethics committee of our hospital approved the study, and all patients provided written informed 
consent. 
2.2. Patient cohort 
Inclusion criteria were age ≥18 yr and the availability of preoperative and postoperative computed 
tomography (CT) or magnetic resonance imaging scans, stage I or II ACC according to the McFarlane-
Sullivan classification (tumour without infiltration of neighbouring structures, positive lymph nodes, or 
distant metastasis) [15] and [16], and complete follow-up information until death or the end of the study 
period. All histologic diagnoses were confirmed by two experienced pathologists at our centre (EB, MV) 
according to the Weiss criteria [17] and [18]. Exclusion criteria were incomplete tumour staging or 
incomplete follow-up data, extensive surgical approach beyond adrenalectomy (eg, nephrectomy, 
resection of pancreas tail, partial hepatectomy), macroscopically incomplete resection, tumour capsule 
violation, conversion from laparoscopic to open surgery, concomitant cancers within the previous 5 yr, and 
clinically significant concomitant diseases. Complete resection was defined as no evidence of macroscopic 
residual disease on the basis of surgical reports, histopathologic analysis, and postoperative imaging. 
Follow-up visits, which included imaging of the chest and abdomen, were performed every 6 mo until 
either disease progression occurred or the study period ended. The first postoperative CT was performed 
within 1 mo following surgery. For the purpose of this analysis, disease recurrence was diagnosed on the 
basis of radiologic evidence of a new lesion during follow-up. Recurrence was defined as local when 
involving the operative site or regional lymph nodes, peritoneal when there was evidence of abdominal 
carcinomatosis, or distant. Local recurrences were further classified as “single” (neoplastic tissue in a 
single site) or “multiple” (two or more sites). Moreover, we evaluated port-site recurrences in patients 
treated laparoscopically. Adjuvant treatment following complete tumour removal and treatment of the 
recurrence were considered. 
Of 56 patients with identified stage I or II ACC, 43 met all entry criteria and were included in the study (Fig. 
1); of these, 12 (28%) were treated at our institution. The patients were stratified into two groups according 
to the surgical procedure. The “open group” consisted of patients treated with open adrenalectomy (OA); 
the “lap group” consisted of patients treated with laparoscopic adrenalectomy (LA). The surgical approach 
was based on surgeon preference and expertise, and the referral pattern was the same for patients treated 
with either methodology. 
 
2.3. Statistical analysis 
All statistical analyses were performed with Statistica software (StatSoft, Inc, Tulsa, OK, USA). Rates and 
proportions were calculated for categorical data and medians and ranges for continuous data. Differences 
in continuous variables were analysed by means of the two-tailed Mann-Whitney U test. For categorical 
variables, differences were analysed by means of the chi-square test. Survival curves were computed 
according to the Kaplan-Meier method and were compared by means of the log-rank test. A Cox 
proportional hazards regression analysis was used to assess in univariate and multivariate analyses the 
predictive role of the treatment (OA vs LA) and of clinical and pathologic variables on disease recurrence. 
All reported p values are two sided. A p value of <0.05 was considered to indicate statistical significance. 
2.4. Study end points 
The primary end point of the study was to evaluate the oncologic effectiveness of the procedures 
comparing the recurrence-free survival of patients treated with OA versus LA. Secondary outcome 
measures were differences in terms of type of recurrence (ie, single or multiple, local or distant) and 
overall survival. 
3. Results 
The open group consisted of 25 patients and the lap group consisted of 18 patients. Table 1 summarises 
the demographic data, characteristics of the lesions, and clinical presentation. As far as surgical details are 
concerned, all patients in the open group were treated with an anterior transperitoneal approach; all 
patients in the lap group were treated with a transperitoneal laparoscopic approach. The median follow-up 
duration of the whole cohort was 35 mo (range: 11–72 mo). 
The two groups were comparable in terms of age; sex; size, stage, and secretory status of tumour; and 
Weiss score. The median follow-up after surgery was 38 mo (range: 11–72 mo) in the open group and 30 
mo (range: 12–54 mo) in the lap group. After adrenalectomy, 15 patients of the open group (60%) and 12 
patients of the lap group (66%) (p = 0.6) were treated adjuvantly with mitotane. 
During follow-up, 16 patients of the open group versus 9 patients of the lap group experienced a 
recurrence. Thus the recurrence rate was 64% in the open group and 50% in the lap group. Median 
recurrence-free survival was 18 mo in the open group and 23 mo in the lap group and did not differ 
significantly according to the log-rank test (p = 0.8). Fig. 2 depicts the Kaplan-Meyer survival curves of the 
two groups. Local recurrences were recorded in 6 patients of both the open and laparoscopic group (p = 
0.5); distant recurrences were observed in 10 patients of the open group and 4 patients of the lap group, 
respectively (p = 0.2). Local recurrences were multiple in five patients of the open group and two patients 
of the lap group, respectively (p = 0.4). No peritoneal or port-site recurrences were observed. Among 
patients in the two groups, recurrences were managed with repeat surgery (26%), mitotane (8%), or 
cytotoxic chemotherapy (30%); these approaches were often used in combination. During follow-up, seven 
patients of the open group (28%) and one patient of the lap group (5%) died due to ACC-related causes. 
Multivariate Cox models were fitted to the data, in which age, tumour stage, and number of mitosis were 
included as covariates together with the treatment group. Table 2 shows the results of the multivariate 
analyses. As far as recurrence-free survival is concerned, treatment modality was not an independent 
prognostic factor (p = 0.3). Due to the low number of events, multivariate analysis was not applicable for 
overall survival time. 
4. Discussion 
Some authors have argued that laparoscopic adrenalectomy can be performed safely in selected patients 
with malignant cortical tumours [11], [19], [20], [21] and [22]. In a previous retrospective study, we reported 
six cases of ACC treated with laparoscopy, and we concluded that LA seemed to be a feasible option [23]. 
In contrast, other authors have urged caution, especially on the basis of anecdotal experience with high 
rates of locoregional recurrence including the development of carcinomatosis [24], [25] and [26]. 
Few other series have been reported, but the number of patients is usually small, the population 
heterogeneous, and the follow-up short. Thus the conclusions are not univocal (Table 3). However, due to 
the rarity of ACC, a randomised, controlled trial comparing OA and LA will likely never be performed. 
This compelled us to study past cases that were retrieved from the ACC database of the San Luigi 
Hospital to do an exploratory analysis and contribute to the discussion on surgical treatment of stage I and 
II ACC. We chose to review the entire database of our centre, and we included all patients with stage I or II 
ACC in whom adrenalectomy was the only surgical treatment, excluding patients in whom nephrectomy or 
more extensive surgery, or conversion of laparoscopic to open, was performed. From the surgical point of 
view, we compared two groups of patients in whom the surgical principles were respected (ie, no tumour 
capsule violation, no residual disease at postoperative imaging), and this, in our opinion, is a strength of 
our study. Although we disclose the limitations of a retrospective analysis, which is subject to selection 
bias, the two groups of patients (OA and LA) were well matched in terms of patient and tumour 
characteristics, as far as the major prognostic factors and adjuvant therapies are concerned. However, the 
possibility that patients with different unmeasured characteristics were unevenly distributed between the 
OA and LA groups cannot be completely excluded. We are also aware that the statistical power of some 
analyses may be rather low due to the limited number of events. Postoperative follow-up was performed at 
our centre according to a standardised protocol for all patients, allowing us to choose recurrence-free 
survival as a valuable study outcome. In addition, we considered that recurrence-free survival is a direct 
expression of the effectiveness of primary surgical therapy, whereas overall survival may be also 
influenced by subsequent treatments that are not well standardised [9], [10] and [27]. 
We have also investigated the pattern of recurrence because some authors have reported a higher rate of 
carcinomatosis in patients treated with laparoscopy [25] and [26]. We did not compare the perioperative 
data of the two groups basically because we focused our attention on oncologic results. However, the 
benefits of laparoscopic adrenalectomy in terms of length of hospital stay, decrease in postoperative pain, 
time to return to preoperative activity level, and cosmetic results are well known [7]. 
The present findings of a comparable recurrence-free survival between patients treated with OA or LA do 
not support that OA is the best surgical treatment in patients with ACC as previously suggested by some 
authors, provided that ACC is diagnosed at stage I or II. The fact that these patients were treated by 
different surgeons reflects the usual clinical practice and makes the present results more reproducible. 
This may have disadvantaged the LA group because LA is more technically demanding and dependent on 
a surgeon's skill; thus, our results may be strengthened by such a consideration. However, surgical 
technique was the same within the groups, with OA performed through an open anterior approach and LA 
with a transperitoneal approach. Also, the comparison between the recurrence patterns observed after OA 
or LA did not differ significantly. Again, these finding do not support the hypothesis that peritoneal 
carcinomatosis or multiple recurrences are more frequent in patients treated with LA. To adjust for 
unintentional bias, multivariate analysis including the factors that more influence ACC recurrence and 
survival was performed [27], [28] and [29]. Results of this analysis confirm that the type of surgical 
treatment is not an independent prognostic factor. Finally, although median survival was not reached in the 
lap group, 3-yr survival rate was not different between the two groups. One should note that the group of 
deceased patients is small, and survival time may be influenced by the multiple treatment modalities used 
during the disease. Thus, definitive conclusions cannot be drawn. Nevertheless, this finding could strength 
the hypothesis that the oncologic effectiveness of open and laparoscopic surgery may be comparable. 
In our opinion, LA is an effective option for surgical treatment of stage I and II ACC, and an expert surgeon 
can reasonably offer this approach to patients. 
5. Conclusions 
Despite the limitations of the present analysis, this study may be considered reliable to address the 
surgical management of a rare tumour like ACC, for which no prospective randomised studies will likely be 
feasible. Although no definitive statistical conclusions can be drawn, there is at least evidence that the 
laparoscopic and open approaches are comparable in the treatment of patients with stage I and II ACC 
when the principles of oncologic surgery are respected. 
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